Food & Health
Osteoarthritis, Obesity, and Type 2 Diabetes: Expl
Osteoarthritis, Obesity, and Type 2 Diabetes: Exploring the Interplay and Clinical Implications

Review explores the links between obesity, type 2 diabetes, and osteoarthritis, focusing on the impact of ectopic (intra-abdominal) fat distribution on disease pathogenesis and progression, with implications for targeted interventions and multidisciplinary management approaches.

Februery 2022

Focusing on Emotions for People Living with Obesit
Focusing on Emotions for People Living with Obesity: Implications for Mental and Physical Health

Participants in obesity management programs experience weight loss and improvements in anxiety, depression, and blood pressure, highlighting the importance of addressing emotional well-being alongside physical health outcomes in individuals living with obesity.

January 2022

Nitazoxanide for COVID-19 Treatment: Regulatory St
Nitazoxanide for COVID-19 Treatment: Regulatory Status Update

Emergency use authorization for nitazoxanide as a potential treatment for COVID-19 is requested from the FDA in the US, signaling ongoing efforts to repurpose existing drugs for combating the pandemic and expanding therapeutic options for affected individuals.

January 2022

Median arcuate ligament syndrome

It is a rare phenomenon caused by extrinsic compression of the celiac trunk by the median arcuate ligament.

December 2021

Obesity and Long-Term Complications of COVID-19: I
Obesity and Long-Term Complications of COVID-19: Implications for Disease Management and Public Health Strategies

Patients with obesity have a 30% higher risk of hospital admission for long-term complications of COVID-19, highlighting the need for targeted interventions and public health initiatives to mitigate disparities and improve outcomes in vulnerable populations.

December 2021

Neurobiological Basis of Hunger Regulation: Implic
Neurobiological Basis of Hunger Regulation: Implications for Obesity Management

Brain circuitry plays a critical role in hunger regulation and satiety signaling, offering potential targets for intervention and pharmacological modulation to address obesity and metabolic disorders.

December 2021

Obesity and cardiovascular risk
Obesity and cardiovascular risk

The essential aspects to take into account

December 2021

FDA and CDC Pause Use of Johnson & Johnson Vaccine
FDA and CDC Pause Use of Johnson & Johnson Vaccine: Safety Concerns

Following reports of rare blood clotting events, the FDA and CDC recommend a pause in the use of the Johnson & Johnson vaccine, highlighting the importance of post-authorization safety monitoring and rapid response to vaccine-related adverse events.

December 2021

Obesity and Hyperinsulinemia: Pathophysiological I
Obesity and Hyperinsulinemia: Pathophysiological Interplay and Clinical Implications

The adverse consequences attributed to obesity may be mediated by hyperinsulinemia, suggesting a complex interplay between metabolic and hormonal factors in obesity-related complications and underscoring the importance of targeted interventions in managing obesity-related health risks.

November 2021

Exercise-Induced Weight Loss: Mechanisms and Strategies

Physical activity may prompt increased food intake, posing challenges to weight loss efforts, understanding underlying mechanisms and implementing strategies to mitigate compensatory eating behaviors are crucial for achieving sustainable weight management goals.

November 2021